Horizon Therapeutics plc Ranks First in Overall Corporate Reputation by Rare Disease Patient Advocacy Groups
| NRMGX Fund | USD 19.96 0.07 0.35% |
Slightly above 62% of Neuberger Berman's investor base is looking to short. The analysis of overall sentiment of trading Neuberger Berman Mid mutual fund suggests that many investors are alarmed at this time. Neuberger Berman's investing sentiment can be driven by a variety of factors including economic data, Neuberger Berman's earnings reports, geopolitical events, and overall market trends.
Neuberger |
DUBLIN, August 23, 2023 Horizon Therapeutics plc today announced that it ranked first in overall corporate reputation among rare disease patient groups around the world who were familiar with the company. Rare disease patient groups who worked with Horizon also ranked the company first in 10 of the 14 indicators including patient centricity, patient information, integrity, access to medicines, relationships and services bey
Read at finance.yahoo.com
 |
Neuberger Berman Fundamental Analysis
We analyze Neuberger Berman's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Neuberger Berman using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Neuberger Berman based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Five Year Return
Five Year Return Comparative Analysis
Neuberger Berman is currently under evaluation in five year return among similar funds. Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
Neuberger Berman Mid Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Neuberger Berman mutual fund to make a market-neutral strategy. Peer analysis of Neuberger Berman could also be used in its relative valuation, which is a method of valuing Neuberger Berman by comparing valuation metrics with similar companies.
Peers
Neuberger Berman Related Equities
| FIFGX | Fidelity Sai | 0.09 | ||||
| GPMFX | Guidepath Managed | 0.13 | ||||
| APISX | Short Duration | 0.19 | ||||
| ABNYX | Ab Bond | 0.29 | ||||
| SWRSX | Schwab Treasury | 0.29 | ||||
| BPRIX | Blackrock Inflation | 0.41 |
Other Information on Investing in Neuberger Mutual Fund
Neuberger Berman financial ratios help investors to determine whether Neuberger Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Neuberger with respect to the benefits of owning Neuberger Berman security.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |